Search research articles
Contact Us
Filters
Showing results (11-20 of 42) with videos related to
Page
of 5
Sort By:
The Journal of Cell Biology
|
April 27, 2017
Oncogenic β-catenin and PIK3CA instruct network states and cancer phenotypes in intestinal organoids
Pamela Riemer, Mattias Rydenfelt, Matthias Marks, et al.
Plos One
|
August 20, 2011
An RNA interference phenotypic screen identifies a role for FGF signals in colon cancer progression
Marc Leushacke, Ralf Spörle, Christof Bernemann, et al.
Current Biology : CB
|
June 7, 2005
A role for E2F6 in the restriction of male-germ-cell-specific gene expression
Michael Pohlers, Matthias Truss, Ute Frede, et al.
Gastroenterology
|
March 31, 2009
A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential
Johannes Fritzmann, Markus Morkel, Daniel Besser, et al.
The Journal of Cell Biology
|
April 5, 2023
Oncogenic signaling is coupled to colorectal cancer cell differentiation state
Thomas Sell, Christian Klotz, Matthias M Fischer, et al.
International Journal of Cancer
|
July 20, 2024
High-confidence calling of normal epithelial cells allows identification of a novel stem-like cell state in the colorectal cancer microenvironment
Tzu-Ting Wei, Eric Blanc, Stefan Peidli, et al.
BMC Biology
|
September 8, 2020
Malignant transformation and genetic alterations are uncoupled in early colorectal cancer progression
Soulafa Mamlouk, Tincy Simon, Laura Tomás, et al.
Development (Cambridge, England)
|
November 19, 2003
Beta-catenin regulates Cripto- and Wnt3-dependent gene expression programs in mouse axis and mesoderm formation
Markus Morkel, Joerg Huelsken, Maki Wakamiya, et al.
Cancer Research
|
November 6, 2020
PWD/Ph-Encoded Genetic Variants Modulate the Cellular Wnt/β-Catenin Response to Suppress <i>Apc</i> <sup>Min</sup>-Triggered Intestinal Tumor Formation
Alexandra L Farrall, Matthias Lienhard, Christina Grimm, et al.
Molecular Cancer Therapeutics
|
March 5, 2022
Triple Targeting of HER Receptors Overcomes Heregulin-mediated Resistance to EGFR Blockade in Colorectal Cancer
Alexander Rau, Nicole Janssen, Lennart Kühl, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 42) with videos related to
Sort By:
Page
of 5
The Journal of Cell Biology
|
April 27, 2017
Oncogenic β-catenin and PIK3CA instruct network states and cancer phenotypes in intestinal organoids
Pamela Riemer, Mattias Rydenfelt, Matthias Marks, et al.
Plos One
|
August 20, 2011
An RNA interference phenotypic screen identifies a role for FGF signals in colon cancer progression
Marc Leushacke, Ralf Spörle, Christof Bernemann, et al.
Current Biology : CB
|
June 7, 2005
A role for E2F6 in the restriction of male-germ-cell-specific gene expression
Michael Pohlers, Matthias Truss, Ute Frede, et al.
Gastroenterology
|
March 31, 2009
A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential
Johannes Fritzmann, Markus Morkel, Daniel Besser, et al.
The Journal of Cell Biology
|
April 5, 2023
Oncogenic signaling is coupled to colorectal cancer cell differentiation state
Thomas Sell, Christian Klotz, Matthias M Fischer, et al.
International Journal of Cancer
|
July 20, 2024
High-confidence calling of normal epithelial cells allows identification of a novel stem-like cell state in the colorectal cancer microenvironment
Tzu-Ting Wei, Eric Blanc, Stefan Peidli, et al.
BMC Biology
|
September 8, 2020
Malignant transformation and genetic alterations are uncoupled in early colorectal cancer progression
Soulafa Mamlouk, Tincy Simon, Laura Tomás, et al.
Development (Cambridge, England)
|
November 19, 2003
Beta-catenin regulates Cripto- and Wnt3-dependent gene expression programs in mouse axis and mesoderm formation
Markus Morkel, Joerg Huelsken, Maki Wakamiya, et al.
Cancer Research
|
November 6, 2020
PWD/Ph-Encoded Genetic Variants Modulate the Cellular Wnt/β-Catenin Response to Suppress <i>Apc</i> <sup>Min</sup>-Triggered Intestinal Tumor Formation
Alexandra L Farrall, Matthias Lienhard, Christina Grimm, et al.
Molecular Cancer Therapeutics
|
March 5, 2022
Triple Targeting of HER Receptors Overcomes Heregulin-mediated Resistance to EGFR Blockade in Colorectal Cancer
Alexander Rau, Nicole Janssen, Lennart Kühl, et al.
Page
of 5